Patients with [TIMP-2]∙[IGFBP7] values > 0.3 (ng/ml)2/1000 have a seven-times higher risk of developing AKI (95% CI 4–22) compared to patients with lower levels14. The gene discussed is IGFBP7; the disease is acute kidney injury.